Moderation of hematological and plasma biochemical indices of sub-chronic salt-loaded rats, by an aqueous extract of the leaves of Acalypha wilkesiana ‘Godseffiana’ Muell Arg (Euphorbiaceae)

Anti-Inflammatory Effect of a Polyphenol-Enriched Fraction from Acalypha wilkesiana on Lipopolysaccharide-Stimulated RAW 264.7 Macrophages and Acetaminophen-Induced Liver Injury in Mice

A polyphenol-enriched fraction (PEF) from Acalypha wilkesiana, whose leaves have been traditionally utilized for the treatment of diverse medical ailments, was investigated for the anti-inflammatory effect and molecular mechanisms by using lipopolysaccharide- (LPS-) stimulated RAW 264.7 macrophages and acetaminophen- (APAP-) induced liver injury mouse model. Results showed that PEF significantly attenuated LPS-induced nitric oxide (NO) and prostaglandin E₂ (PGE₂) production and suppressed the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) in RAW 264.7 macrophages. PEF also reduced the secretion of proinflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin- (IL-) 1β, and IL-6 in LPS-stimulated RAW 264.7 macrophages. Moreover, PEF potently inhibited LPS-induced phosphorylation of mitogen-activated protein kinases (MAPKs) as well as the activation of nuclear factor-κB (NF-κB) by preventing the degradation of inhibitor κB-α (IκB-α). In vivo, PEF pretreatment ameliorated APAP-induced liver injury and hepatic inflammation, as presented by decreased hepatic damage indicators and proinflammatory factors at both plasma and gene levels. Additionally, PEF pretreatment remarkably diminished Toll-like receptor 3 (TLR3) and TLR4 expression and the subsequent MAPKs and NF-κB activation. HPLC analysis revealed that two predominantly polyphenolic compounds present in PEF were geraniin and corilagin. These results indicated that PEF has an anti-inflammatory effect, and its molecular mechanisms may be involved in the inactivation of the TLR/MAPK/NF-κB signaling pathway, suggesting the therapeutic potential of PEF for inflammatory diseases.

Medicinal plants from the genus Acalypha (Euphorbiaceae)--a review of their ethnopharmacology and phytochemistry

ETHNOPHARMACOLOGICAL RELEVANCE

Acalypha is the fourth largest genus of the Euphorbiaceae family with approximately 450-570 species. Several Acalypha species are used as medicinal plants in Africa and in the Mascarene Islands. Almost every part of the plant including the leaves, stem and roots are used as traditional remedies to treat and manage a panoply of ailments. However, there is no updated compilation of traditionally important medicinal plants from the Acalypha genus. The present review therefore, endeavors to provide for the first time an updated compilation of documented ethnopharmacological information in relation to the ethnomedicinal, ethnoveterinary, zoopharmacognosy, phytochemistry and biological activities of medicinal plants from the Acalypha genus which can subsequently open new perspectives for further pharmacological research.

MATERIALS AND METHODS

A literature search was performed on Acalypha species using ethnobotanical text books and scientific databases such as Pubmed, Scopus, EBSCO, Google Scholar and other web sources such as records from PROTA, PROSEA, and Botanical Dermatology Database. The Plant List, International Plant Name index and Kew Botanical Garden Plant name databases were used to validate scientific names.

RESULTS AND DISCUSSION

Plants from Acalypha genus are traditionally used in the treatment and/or management of diverse ailments such as diabetes, jaundice, hypertension, fever, liver inflammation, schistosomiasis, dysentery, respiratory problems including bronchitis, asthma and pheumonia as well as skin conditions such as scabies, eczema and mycoses. Approximately 124 species were listed in ethnobotanical studies with some botanical description and others mentioned from different web sources. However, only 40 species have been included in the present review due to the unavailability of ethnopharmacological data on the remaining species. Among the 40 cited species, 30 were traditionally used for the treatment and/or management of approximately 70 human diseases or health conditions. Two species, Acalypha alnifolia and Acalypha fruticosa are used as insecticides and sand fly repellent respectively. Only 2 species (Acalypha fruticosa and Acalypha indica) are used in ethnoveterinary practice and have similar human and veterinary applications. In zoopharmacognosy, only Acalypha ornata has been mentioned. Natives from Africa, Central America, North America, Southern China, India, Bangladesh, Papua New Guinea and Mascarenes islands utilize Acalypha species as ethnomedicine. Traditionally used Acalypha species have been reported to possess at least one of the following biological activities: antimicrobial, anti-diabetic, antioxidant, anti-inflammatory, larvidal, pupicidal, hepatoprotective, anticancer, leishmanicidal, antihyperglycemic, antihypertensive, anti-venom, analgesic, anthelmintic, antiemetic, laxative, expectorant, diuretic, post-coital antifertility effects and wound healing. A total of 167 compounds have been identified from 19 species, with 16 from eight species were reported to be bioactive.

CONCLUSION

The present review represents 32.3% of species from the Acalypha genus and can be considered as the first compilation of ethnopharmacologically useful plants from this genus. There is a great potential to discover new biologically active phytochemicals from the Acalypha genus because only few species have been studied comprehensively. Therefore, the clinical evaluation of species from this genus is warranted in future studies to confirm the ethnomedicinal claims and for the safety approval of therapeutic applications.

Moderation of hematological and plasma biochemical indices of sub-chronic salt-loaded rats by aqueous extract of the sclerotia of Pleurotus tuberregium (Fr) Sing's: implications for the reduction of cardiovascular risk

ETHNOPHARMACOLOGICAL RELEVANCE

The sclerotia of Pleurotus tuberregium are used in Southern Nigeria for the management of diabetes and hypertension, yet there is scarcity of information in the literature regarding the evaluation of the biochemical basis of its antihypertensive property, as well as the biochemical impact of its administration to the hypertensive. Thus, in this study, the ability of an aqueous extract of the sclerotia of Pleurotus tuberregium to moderate biochemical and hematological indices was investigated in normal and sub-chronic salt-loaded rats.

MATERIALS AND METHODS

The normal and treatment control groups received a diet consisting 100% of the commercial feed, while the test control, reference and test treatment groups received an 8% salt-loaded diet. The extract was orally administered daily at 100 and 200 mg/kg body weight; while the moduretics was administered at 1 mg/kg. The normal and test control groups received appropriate volumes of water by the same route.

RESULTS

On gas chromatographic analysis of the crude aqueous extract, 29 known flavonoids (mainly 47.71% kaempferol and 37.36% quercetin), four saponins (mainly 72.93% avenacin B1 and 26.80% avenacin A1), six hydroxycinnamic acid derivatives (mainly 57.57% p-coumaric and 42.10% caffeic acid), ten carotenoids (mainly 58.44% carotene and 28.16% lycopene) and seven phytosterols (mainly 98.16% sitosterol) were detected. Also detected were nine benzoic acid derivatives (mainly 44.19% ferulic acid and 25.92% rosmarinic acid), six lignans (mainly 70.88% galgravin and 22.69% retusin), three allicins (mainly 71.92% diallyl thiosulphinate and 23.68% methyl allyl thiosulphinate), seven glycosides (mainly 84.86% arbutin and 12.01% ouabain), 31 alkaloids (mainly 48.82% lupanine, 32.26% augustamine) and 24 terpenes (mainly 60.66% limonene and 6.52% geranyl acetate). Compared to test control, the treatment significantly, dose-dependently lowered (P < 0.05) the mean cell volume, atherogenic indices (cardiac risk ratio, atherogenic coefficient and atherogenic index of plasma), plasma alanine and aspartate transaminase activities, mean cell hemoglobin, sodium, bicarbonate, urea, blood urea nitrogen, triglyceride, total-, non-high density lipoprotein-, low density lipoprotein- and very low density lipoprotein cholesterol concentrations, and neutrophils, monocytes and platelets counts of the treated animals. However, it significantly, dose-dependently increased (P < 0.05) the hemoglobin concentration, mean cell hemoglobin, red cells and lymphocytes counts, plasma high density lipoprotein cholesterol, calcium, potassium, chloride, creatinine, albumin and total protein concentrations of the treated animals.

CONCLUSIONS

All these results support the use of the plant in traditional health care, for the management of hypertension, and highlight the cardio-protective potential of the sclerotia, whilst suggesting that its antihypertensive activity may be mediated through alteration of plasma levels of sodium and potassium, or increases in muscle tone brought about by changes in plasma calcium levels.